Geron (GERN) FCF Margin (2010 - 2026)

Geron's (GERN) quarterly FCF Margin came in at 121.35% in Q1 2026, down 20.0% year-on-year from 151.69% in Q1 2025, and down 630.01% quarter-over-quarter from 22.9% in Q4 2025.

Geron (GERN) FCF Margin (2010 - 2026) Analysis & Trends

Geron has disclosed FCF Margin across 17 years of filings, most recently posting 121.35% for Q1 2026.

  • FCF Margin for Q1 2026 came in at 121.35%, down 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 243.54% (down 6702.0% YoY), and the FY2025 annual result was 281.18%, up 548.0% from the prior year.
  • FCF Margin came in at 121.35% for Q1 2026 at Geron, down from 22.9% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 19159.81% in Q4 2023 to a low of 222557.14% in Q1 2023.
  • The 5-year median for FCF Margin is 208.49% (2024), against an average of 25558.95%.
  • Across the five-year window, FCF Margin slumped 19489535 bps in 2023 and jumped 20187688 bps in 2024, its largest moves.
  • Geron's FCF Margin stood at 7164.5% in 2022, then jumped by 167 bps to 19159.81% in 2023, then slumped by 100 bps to 93.11% in 2024, then surged by 125 bps to 22.9% in 2025, then slumped by 630 bps to 121.35% in 2026.
  • The last three FCF Margin figures came in at 121.35% (Q1 2026), 22.9% (Q4 2025), and 28.75% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 43.35%
9 Abivax 91.71 Bn 91.71 Bn - -
10 Geron 729,618.77 729,618.77 - -121.35%

Historic Data

Download Data
DateValue
Mar 31, 2026 -121.35%
Dec 31, 2025 22.90%
Sep 30, 2025 -28.75%
Jun 30, 2025 -55.91%
Mar 31, 2025 -121.15%
Dec 31, 2024 -93.11%
Sep 30, 2024 -208.49%
Jun 30, 2024 -6,086.62%
Mar 31, 2024 -20,680.26%
Dec 31, 2023 19,159.81%
Sep 30, 2023 -31,116.46%
Jun 30, 2023 -102,768.97%
Mar 31, 2023 -222,557.14%
Dec 31, 2022 7,164.50%
Sep 30, 2022 -10,017.85%
Jun 30, 2022 -39,331.51%
Mar 31, 2022 -27,661.79%
Dec 31, 2021 -2,141.44%
Sep 30, 2021 -21,040.37%
Jun 30, 2021 -16,648.60%